Form 4: Corcept Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Sean Maduck, See Remarks of Corcept Therapeutics Inc, sold 20,305 shares of common stock on August 3, 2026 for $114.70 per share.
Summary
- Option exercise/conversion: acquired 20,305 Common Stock at $8.27 ($167,922) on August 3, 2026; holds 30,060 after (Direct).
- Open-market sale: disposed of 20,305 Common Stock at $114.70 ($2,329,075) on August 3, 2026; holds 9,755 after (Direct).
- Option exercise/conversion: disposed of 20,305 Stock option (right to buy) on August 3, 2026; holds 96,681 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,329,075 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Sean Maduck — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Option exercise/conversion | Common Stock | 20,305 | $8 | $167.9K | 30,060 |
| 2026-08-03 | Open-market sale | Common Stock | 20,305 | $115 | $2.3M | 9,755 |
| 2026-08-03 | Option exercise/conversion | Stock option (right to buy) | 20,305 | — | — | 96,681 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Option exercise/conversion (20,305 shares) |
| 2026-08-03 | Open-market sale (20,305 shares) |
| 2026-08-03 | Option exercise/conversion (20,305 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Sean Maduck
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.